Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome after treatment for sebaceous carcinoma: A multicenter study.
In 't Veld EH, Keizer R, Post N, Versteeg J, Verdijk R, Naus N, Relyveld G, Crijns M, Smith M, Grünhagen D, Wakkee M, Paridaens D, Zavrakidis I, Mooyaart A, van Akkooi A, Strauss D, Verhoef C, Wouters M, Hayes A, van Houdt W. In 't Veld EH, et al. Among authors: paridaens d. J Surg Oncol. 2022 Mar;125(4):730-735. doi: 10.1002/jso.26774. Epub 2022 Jan 6. J Surg Oncol. 2022. PMID: 34990031 Free PMC article.
Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, Brüggenwirth HT, van Ijcken W, Paridaens D, Luyten GP, de Klein A. van Gils W, et al. Among authors: paridaens d. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4254-62. doi: 10.1167/iovs.08-2033. Epub 2008 Jun 14. Invest Ophthalmol Vis Sci. 2008. PMID: 18552379
Chromosome 3 intratumor heterogeneity in uveal melanoma.
Mensink HW, Vaarwater J, Kiliç E, Naus NC, Mooy N, Luyten G, Brüggenwirth HT, Paridaens D, de Klein A. Mensink HW, et al. Among authors: paridaens d. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-4. doi: 10.1167/iovs.08-2279. Epub 2008 Sep 29. Invest Ophthalmol Vis Sci. 2009. PMID: 18824727
Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Brüggenwirth HT, Kiliç E, de Klein A. Vaarwater J, et al. Among authors: paridaens d. Melanoma Res. 2012 Feb;22(1):30-7. doi: 10.1097/CMR.0b013e32834e6a67. Melanoma Res. 2012. PMID: 22157614
169 results